Efficacy and safety of intradermal vaccination against porcine circovirus type 2 and Mycoplasma hyopneumoniae under combined exposure field conditions

被引:0
|
作者
Panagiotis Tassis [1 ]
Suzanne Pel [2 ]
Dimitrios Floros [1 ]
Kim ter Haar [2 ]
Qi Cao [2 ]
Ioannis Tsakmakidis [1 ]
Vassileios Papatsiros [3 ]
Niki Ntarampa [1 ]
Ioannis Arsenakis [4 ]
Eleni D. Tzika [1 ]
机构
[1] Farm Animals Clinic, School of Veterinary Medicine, Aristotle University of Thessaloniki, Thessaloniki
[2] MSD Animal Health, Boxmeer
[3] Clinic of Medicine, School of Veterinary Medicine, University of Thessaly, Karditsa
[4] Laboratory of Anatomy & Physiology of Farm Animals, Agricultural University of Athens, Athens
关键词
Enzootic pneumonia; Intradermal vaccination; Lung lesions; Mycoplasma hyopneumoniae; Pigs; Pleurisy; Porcine circovirus type 2; Porcine respiratory disease complex; Viraemia;
D O I
10.1186/s40813-025-00431-y
中图分类号
学科分类号
摘要
Background: Porcine circovirus 2 (PCV2) and Mycoplasma hyopneumoniae (M hyo) are two of the most important swine pathogens with variable clinical presence in swine farms globally, affecting health and performance of pigs under field conditions. The primary objective of this study was to assess the efficacy of a ready to use intradermal (ID) vaccine (Porcilis PCV M Hyo ID, MSD Animal Health, The Netherlands) against PCV2 associated disease and M hyo associated enzootic pneumonia under practical (field) conditions. In addition, the safety of the test product was clinically assessed, as the study animals were examined for general and local side effects after vaccination. A total of 678 animals in a Greek farrow to finish farm were equally divided in two trial groups (test and control group). Test group animals received the test vaccine at the age of three weeks, while control group animals remained unvaccinated. Parameters regarding health [lung lesion score (LLS) and pleurisy scoring, PCV2 viraemia and shedding] and performance [body weight (BW), average daily weight gain (ADWG)] were recorded and evaluated. Results: Vaccination improved the ADWG during both the finishing period (improvement by 34 g; p < 0.0001), and the overall period (increase by 24 g; p < 0.0001). Moreover, reduced mean LLS values (p < 0.0001), as well as reduced percentage of animals with pleurisy (p = 0.0082) and a decrease in PCV2 viraemia (p < 0.0001) and viral shedding (p = 0.0181) were observed in vaccinated animals when compared with the unvaccinated controls. As regards safety, a slight local skin reaction at the site of vaccination was detected and in two pigs a mild systemic reaction was reported with full recovery. Conclusions: Findings suggested that the test vaccine is safe and effective against both PCV2 and M hyo associated diseases in vivo, thus it’s use as part of a vaccination programme under field conditions is expected to improve respective health and performance parameters in pigs. © The Author(s) 2025.
引用
收藏
相关论文
共 50 条
  • [1] Field study on the safety and efficacy of intradermal versus intramuscular vaccination against Mycoplasma hyopneumoniae
    Beffort, Lisa
    Weiss, Christine
    Fiebig, Kerstin
    Jolie, Rika
    Ritzmann, Mathias
    Eddicks, Matthias
    VETERINARY RECORD, 2017, 181 (13) : 348
  • [2] Field trial on the simultaneous vaccination against porcine circovirus type 2 (PCV2) and Mycoplasma hyopneumoniae
    Herbich, E.
    Heissenberger, B.
    Ladinig, A.
    Griessler, A.
    Ritzmann, M.
    Weissenbacher-Lang, C.
    Hennig-Pauka, I.
    TIERAERZTLICHE PRAXIS AUSGABE GROSSTIERE NUTZTIERE, 2013, 41 (05): : 279 - 288
  • [3] Efficacy of Simultaneous Intradermal Vaccination of Swine against Porcine Circovirus 2, Porcine Reproductive and Respiratory Syndrome Virus, Mycoplasma hyopneumoniae and Lawsonia intracellularis
    Horsington, Jacquelyn
    Witvliet, Maarten
    Jacobs, Antonius A. C.
    Segers, Ruud P. A. M.
    ANIMALS, 2021, 11 (08):
  • [4] Comparison of Mycoplasma hyopneumoniae and porcine circovirus 2 commercial vaccines efficacy when applied separate or combined under experimental conditions
    Sibila, M.
    Guevara, G.
    Cuadrado, R.
    Pleguezuelos, P.
    Perez, D.
    Perez de Rozas, A.
    Huerta, E.
    Llorens, A.
    Valero, O.
    Perez, M.
    Lopez, C.
    Krejci, R.
    Segales, J.
    PORCINE HEALTH MANAGEMENT, 2020, 6 (01)
  • [5] Efficacy of a new bivalent vaccine of porcine circovirus type 2 and Mycoplasma hyopneumoniae (Fostera™ PCV MH) under experimental conditions
    Park, Changhoon
    Jeong, Jiwoon
    Choi, Kyuhyung
    Chae, Chanhee
    VACCINE, 2016, 34 (02) : 270 - 275
  • [6] Efficacy of a novel bivalent vaccine containing porcine circovirus type 2d and Mycoplasma hyopneumoniae against a dual PCV2d and Mycoplasma hyopneumoniae challenge
    Ham, Sehyeong
    Suh, Jeongmin
    Oh, Taehwan
    Kim, Chonghan
    Seo, Byoung-Joo
    Chae, Chanhee
    FRONTIERS IN VETERINARY SCIENCE, 2023, 10
  • [7] Field efficacy study of a novel ready-to-use vaccine against mycoplasma hyopneumoniae and porcine circovirus type 2 in a Greek farm
    Tzika E.D.
    Tassis P.D.
    Koulialis D.
    Papatsiros V.G.
    Nell T.
    Brellou G.
    Tsakmakidis I.
    Porcine Health Management, 1 (1)
  • [8] A field efficacy and safety trial in the Netherlands in pigs vaccinated at 3 weeks of age with a ready-to-use porcine circovirus type 2 and Mycoplasma hyopneumoniae combined vaccine
    Kaalberg, Luuk
    Geurts, Victor
    Jolie, Rika
    PORCINE HEALTH MANAGEMENT, 2017, 3
  • [9] Optimal vaccination strategy against Mycoplasma hyopneumoniae, porcine reproductive and respiratory syndrome virus, and porcine circovirus type 2 in case of early M. hyopneumoniae infection
    Yang, Siyeon
    Oh, Taehwan
    Mago, Josuke
    Iwakuma, Akihiro
    Chae, Chanhee
    VETERINARY MEDICINE AND SCIENCE, 2020, 6 (04) : 860 - 874
  • [10] Comparative field efficacy of all-in-one intradermal vaccine based on an inactivated recombinant Mycoplasma hyopneumoniae with an embedded/integrated porcine circovirus type 2 (PCV2) capsid protein and concurrent administration with monovalent of M. hyopneumoniae and PCV2 intradermal vaccine
    Suh, Jeongmin
    Ham, Sehyeong
    Chae, Chanhee
    FRONTIERS IN VETERINARY SCIENCE, 2025, 12